Remembering public health pioneer Barry Bloom: a scientist, a mentor, a mensch. www.statnews.com/2026/03/30/b...

Check our new preprint by Knopp M. et al.! Human gut microbiomes can impose strong +/- selection for resistant versions of resident opportunistic pathogens. In the case we follow up, selection is driven by altered carbohydrate utilisation that the resistant mutant evolves. doi.org/10.64898/202...

Congratulations Valerie Mizrahi valmizrahi.bsky.social 🦠 🧪 #WomenInStem #TB www.nasonline.org/news/2026-na...

Rockefeller's Vanessa Ruta and Thomas Tuschl have been elected to the @nasonline.org! Congratulations 🎉 🔗: https://bit.ly/4vTZgQ8

Very pleased that after a rigorous (and lengthy) review process, our paper visualizing how myosin generated forces modulate actin filament structure for mechanosensitive recogntion by α-catenin has appeared in @nature.com : www.nature.com/articles/s41...

Except in GCs theonion.com/biologists-c...

Discovery of gene functions in #Mycobacterium #tuberculosis has been slow. This study tests a genome-wide barcoded #transposon library across 95 environmental conditions, providing a rich resource of new gene functions, including metabolic & resistance pathways @plosbiology.org 🧪 plos.io/4vG0mz1

By editing blood stem cells, the Nussenzweig lab shows that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins--opening the door to potential single-shot treatments for diseases ranging from HIV to cancer. 🔗: https://bit.ly/4cgDoqp

💥Our latest @embojournal.org on membrane damage and repair. Di @dichen02.bsky.social @crick.ac.uk found that calcium is a conserved signal for ATG8/LC3 lipidation on membranes using novel probes to record calcium leakage. Congratulations Di et al! link.springer.com/article/10.1...

Our lab is hiring! As our fierce technician is moving on to graduate school (GO ANNA!), we’re looking for a new tech to join our team studying bacteria-phage interactions. Ideal for recent grads interested in molecular biology and microbiology - please reach out with a CV to [email protected].

Now this is the future of TB research 👏 39 Keystone Symposia & @gatesfoundation.bsky.social scholarship awardees at #KSTB26. With ~1.5M TB deaths each year, these early-career scientists are driving progress through collaboration and new ideas. @maxgg.bsky.social @breealdridge.bsky.social

Unbelievably proud of the work that everyone has put into this paper. Really grateful for such fab colleagues! Mycobacteria continue to be (subjectively) the most interesting bacteria 🤭

We've been we've been working on this for quite a while now (hopefully published soon). Grateful to @proftracypalmer.bsky.social for concinving me & @lislowe.bsky.social that mycobacteria produce inter-bacterial toxins. Team science, led by @sambenedict5.bsky.social www.biorxiv.org/content/10.6...

Latest for @nejm.org, an attempt to bring much-needed attention to these challenging ID cases that for some reason receive so little attention -- NTM. #IDSky Nontuberculous Mycobacteria: The Common Infections You’ve Possibly Never Heard Of | NEJM Voices voices.nejm.org/doi/full/10....

Most mass spectrometers still analyze molecules one or just a few at a time. Now, a new MultiQ-IT prototype from Rockefeller's Brian Chait can cool, trap, filter, and redirect over a billion ions simultaneously. 🔗: https://bit.ly/47FWUd6

Angelika Amon was an inspiration, and I’m deeply grateful for my time in her lab. Please encourage PhD students outside the US who embody her excellence in research & infectious passion for biology to apply. ki.mit.edu/events/prize...

I’m pleased 🤗 to share our new preprint exploring the mode of action and resistance of the antitubercular drug pyrazinamide (PZA) 💊 Thanks to everyone who have participated 🙌 We hope these findings will help the fight against drug resistance in tuberculosis. www.biorxiv.org/content/10.6...

How can we tap into the enormous functional diversity of microbes on this planet? Join us at EMBL Heidelberg (8–10 Dec 2026) to learn about ongoing efforts to decode gene function and organisation in human gut microbes, and present your science.

Very excited to share our latest preprint, where we visualize the impact of force on the catch bonding actin crosslinker α-actinin-4. Led by @tri-i.bsky.social MD-PhD student Alfred Chin, a great collaboration with Glen Hocky's lab. www.biorxiv.org/content/10.6...

I've written a review on what I think is an extremely exciting direction in cryo-EM: Cryo-EM of endogenous membrane proteins in their native lipid bilayer Open access in Quarterly Reviews of Biophysics: doi.org/10.1017/S003...

We are searching for a tenure-track junior faculty member. Join our collaborative research environment in the Department of Microbiology and Immunology at WCM. Please see the link to the job posting and distribute among your networks! apply.interfolio.com/181869

Congrats Brendan, Clif, David, and team! www.nature.com/articles/s41...

Congrats Ruby, Bob, Liz, and team! www.sciencedirect.com/science/arti...

Congrats @oneyrolles.bsky.social and team!

A new frontier for our lab! After many months of development by postdoc @ranaabdelaziz.bsky.social (our resident medicinal chemistry - now also an excellent structural biologist) and the staff at the SickKids Drug Discovery platform, we're conducting our first proof-of-principle inhibitor screen.

#Microbiology The anti-tuberculosis drug bedaquiline targets the mycobacterial ATP synthase, but how that leads to bacterial death is unclear Here the authors clarify how bedaquiline works @jnblab.bsky.social @morwan.me #TBSky #antibiotics #AMR http://dlvr.it/TQjZ0W

Congrats @tobinlab.bsky.social!

Many of you in the mycobacterial community attended the awesome inaugural 2025 Biology of Mycobacteria GRC, organized by @heran.bsky.social and myself: www.grc.org/biology-of-m.... I am writing with an update about this conference as the new chair.

Check out our exciting new paper out now in @plos.org where Dr Ahmad manipulated #peptidoglycan chemistry to understand Lyme disease and arthritis 👇👏 #Microsky #glycotime journals.plos.org/plospathogen...

I’m thrilled to share our work on phage triggers of the bacterial immune system in its final form @natmicrobiol.nature.com www.nature.com/articles/s41...

Congrats @regolab.bsky.social! www.pnas.org/doi/10.1073/...

The Barber lab is looking to hire post-docs to work on #tuberculosis #immunology using murine and NHP models. BSL3 experience not required. Check out our lab in the NIH intramural program in Bethesda MD!

A study in @science.org from Paul Cohen's lab, led by @maschakoenen.bsky.social, demonstrates how beige fat directly influences blood pressure. The findings offer a new target for treating vascular disease and could lead to more precise therapies for hypertension: https://bit.ly/4pK0hGh

We are hiring new faculty!! Come join our amazing community in the Department of Molecular Microbiology at Washington University School of Medicine! The deadline for applications is 2/21, but applications will be reviewed on a rolling basis. facultyopportunities.wustl.edu/Posting/Deta...

Congrats @maxgg.bsky.social and team! This looks very cool.

Lab-grown lung models have traditionally been grown from a mixture of cells, making it hard to tell how a disease or treatment will affect an individual person. These new models by @maxgg.bsky.social’s team and AlveoliX are grown from a single person’s stem cells ⤵️ www.crick.ac.uk/news/2026-01...

The @ragoninstitute.bsky.social is launching a new faculty search for a computational immunologist! Applications are open now and reviewed on a rolling basis. Please share broadly with your networks! #immunosky www.nature.com/naturecareer...

Congrats Luiz and colleagues. Important work!

While everyone is hustling for the holidays, hopefully folks will have time to submit abstracts or register for #ASMMicrobe2026 in DC! Please repost!

We’re heading for one thousand ⭐️ signatures today! Thank you to all who have signed and shared so far, Still plenty of other people to reach before we all wrap up for the holidays, so send family and friends the petition link as an early resolution for a happier New Year! c.org/rstb5XTvns

Two pieces of fun news: 1. We've launched a new website for our lab: www.brysonlab.org 2. With some new funding, we are recruiting for new postdocs and graduate students. The projects build upon our previous studies of antigen presentation and phagosome biology and go into new exciting dimensions!

🚨 𝐍𝐞𝐰 𝐩𝐫𝐞𝐩𝐫𝐢𝐧𝐭 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐥𝐚𝐛, 𝐚𝐧𝐝 𝐚 𝐟𝐢𝐫𝐬𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐓𝐁 𝐟𝐢𝐞𝐥𝐝! 🚨 We’re thrilled to share our new study revealing how the chromatin regulator SP140 preserves protective T cell immunity during #tuberculosis infection by restraining harmful type I IFN responses. 📖 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗽𝗿𝗲𝗽𝗿𝗶𝗻𝘁: shorturl.at/r5jd9

Congrats to @alercher.bsky.social of the #RiceLab, who has won the 2025 Sidney & Joan Pestka Post-Graduate Award from the @cytokinesociety.bsky.social#RiceLab

🔬 Call to create junior research groups at the Institut Pasteur Focus: Infectious diseases, host-microbe interactions, vaccines Special interest: AI methodologies 📅 Deadline: Feb 9, 2026 👥 2-12 years post-PhD Apply now 📝 research.pasteur.fr/en/call/crea... #JobOpportunity #Research

Mycobacterium tuberculosis is an outlier in many ways. One of them is keeping a high degree of functional redundancy despite its obligate pathogen lifestyle. In this review, we reflect on the biological meaning of M. tuberculosis functional redundancies. journals.plos.org/plospathogen...

Hey friends. I’m looking for a postdoc interested in studying host-pathogen interactions and immunology of tuberculosis. Send me some good people! We have a great group here! Email me [email protected]. Thanks!

Antibiotic resistance mutations boost bacterial fitness in the presence of drug but can decrease fitness in its absence. We & others showed that the fitness cost of the most common rifampicin-resistance mutation in M. tuberculosis stems largely from excessive transcriptional termination.

🚀 Latest paper form the lab is now out at @febsopenbio.bsky.social @febspress.bsky.social 🔵⚪🔴 We use CRISPRi tools from the @rocklabtb.bsky.social to target essential genes and control smooth to rough transition in M.smegmatis & M.abscessus 🦠🧫👇👇👇 febs.onlinelibrary.wiley.com/doi/10.1002/...

New research from Rockefeller's Michel Nussenzweig and colleagues finds one particular class of immune cells appears to play a crucial role in achieving a functional cure among people with HIV. #worldAIDSday

New Rockefeller research from Michael Rout and Brian Chait finds that nuclear pore complex (NPC) machinery is an extraordinarily dynamic system, offering new insights into diseases such as #cancer and #neurodegeneration that are linked to NPC breakdown: https://bit.ly/3KAlrIk